VANCOUVER, British Columbia, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) the “Company” or “Isodiol” is pleased to announce the
appointment of Mr. Trent Gray as channel manager of the Iso-Sport Golf Division.
With an undeniable passion for golf spanning nearly four decades, Gray’s experience in the sport from the fairway to the
clubhouse is impressive. He was introduced to golf at the age of 8 and began playing and winning local club tournaments and junior
championships just a few short years later.
He would go on to compete at a high level in district and state tournaments throughout his youth. Before his first year of
college was over, Gray was offered his first official job in golf as an Assistant Golf Professional. This began a career in the
industry with jobs ranging from Tournament Director to Head Golf Professional.
Between managing the day-to-day activities of a golf course and its pro shop, Gray became proficient at technical project
management while building business relationships. He uses his technical skills to provide real results and positively influence the
marketplace.
Currently, Trent competes on the Golf Channel Am Tour where he has posted several impressive finishes in tournaments, including
winning multiple times. He also enjoys promoting the game every chance he gets through junior clinics and tournaments.
Gray has embraced the opportunity to work with Iso-Sport: “To be able to effectively market the benefits of CBD performance
products to golfers and develop meaningful relationships is something I’m definitely looking forward to,” he said.
“We’re thrilled to add Trent Gray to our team. He possesses a wealth of knowledge about the golf industry and his lifelong
experience in the sport is very impressive,” said Isodiol CEO, Marcos Agramont. “We believe his unique skill set will provide added
value to the division as we continue to seek new opportunities while growing our footprint within various sports markets,” added
Agramont.
About Isodiol International Inc.
Isodiol International Inc. is focused on the development of CBD-based pharmaceuticals and CBD
consumer products. With a dedicated passion for the industry it serves, the company’s mission is to create a cultural movement by
building awareness and social acceptance, ultimately empowering people to live better lives – globally. This mission is enacted
through unique divisions and subsidiaries that help deliver the powerful benefits of CBD to people around the world.
Since its inception, Isodiol® has directed its efforts toward advancing CBD research, education, development,
and manufacturing. The company has made tremendous strides in the CBD space through clinical research and forging valuable
partnerships that have allowed the manufacturing of goods in accordance with strict industry practices and standards.
BSPG Laboratories™, a subsidiary of Isodiol®, was recently registered with the United Kingdom’s Medicines and
Healthcare products Regulatory Agency (MHRA) for producing CBD as an active pharmaceutical ingredient (API) for use in
pharmaceutical applications for humans and animals.
Isodiol® is a publicly-traded entity with corporate offices based in Vancouver, Canada, and additional
operations in the United States, South America, and the U.K. For more information about Isodiol®, please visit https://isodiol.com or call (855) 979-6751.
Join Us On Facebook: https://www.facebook.com/IsodiolInternationalInc/
Twitter: @Isodiolintlinc
ON BEHALF OF THE BOARD
Marcos Agramont, CEO & Director
INVESTOR RELATIONS:
Ir@isodiol.com
604-409-4409
MEDIA CONTACT:
Christopher Hussey
media@isodiol.com
Forward-Looking Information: This news release contains "forward-looking
information" within the meaning of applicable securities laws relating to statements regarding the Company's business, products and
future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the
expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will
prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking
statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially
from those contemplated by these statements depending on, among other things, the risks that the Company's products and plan will
vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as
required by law, the Company expressly disclaims any obligation and does not intend, to update any forward-looking statements or
forward-looking information in this news release. Although the Company believes that the expectations reflected in the
forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no
reference to profitability based on sales reported. The statements in this news release are made as of the date of this
release.
The CSE has not reviewed, approved or disapproved the content of this press release.
